about
Identification of hub genes of pneumocyte senescence induced by thoracic irradiation using weighted gene co‑expression network analysisMolecular signatures mostly associated with NK cells are predictive of relapse free survival in breast cancer patients.B cells and macrophages pursue a common path toward the development and progression of chronic lymphocytic leukemia.A combination of an anti-SLAMF6 antibody and ibrutinib efficiently abrogates expansion of chronic lymphocytic leukemia cellsCD24, CD27, CD36 and CD302 gene expression for outcome prediction in patients with multiple myeloma.T Cells Regulate Peripheral Naive Mature B Cell Survival by Cell-Cell Contact Mediated through SLAMF6 and SAP.A phase I-II clinical trial of the anti-CD74 monoclonal antibody milatuzumab in frail patients with refractory chronic lymphocytic leukaemia: A patient based approach.Signaling Lymphocyte Activation Molecule Family 5 Enhances Autophagy and Fine-Tunes Cytokine Response in Monocyte-Derived Dendritic Cells via Stabilization of Interferon Regulatory Factor 8.Ibrutinib and idelalisib block immunophenotypic changes associated with the adhesion and activation of CLL cells in the tumor microenvironment.CD84 mediates CLL-microenvironment interactions.Signaling lymphocytic activation molecules Slam and cancers: friends or foes?Altered expression pattern of SLAM family receptors on pathological B cells of patients with chronic lymphocytic leukemia.
P2860
Q28396973-74C86ADE-02C9-49C3-97AF-96A6407464D4Q36960012-56550C14-DA62-40E6-8ED9-719B65F29178Q38966197-FA0EDC5E-F721-4159-9F24-4A2531AF4A59Q39877099-C366FA44-9638-4089-86EB-D47C9E16763BQ47125786-29BB2855-8719-454E-85D1-B18C41736CD3Q47806755-D1075F6A-BD31-4FA5-BEF3-5A8FE2058A0EQ48200903-B7CF523D-A35B-4447-9284-5329AC58BE30Q49647305-34132EDC-2181-484D-B976-828D31C922E0Q49818504-415CBB41-B9EA-4458-99E0-8AECC4BC82AEQ51620105-310C5E10-F3CC-4877-A470-4576B1F8E320Q52584346-A9BF164C-08BE-421E-A5A7-CAE538BAF3C0Q53804333-C938FECC-885F-4460-8BAB-F89A6B1BD228
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 25 February 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
CD84 is a survival receptor for CLL cells.
@en
CD84 is a survival receptor for CLL cells.
@nl
type
label
CD84 is a survival receptor for CLL cells.
@en
CD84 is a survival receptor for CLL cells.
@nl
prefLabel
CD84 is a survival receptor for CLL cells.
@en
CD84 is a survival receptor for CLL cells.
@nl
P2093
P2860
P356
P1433
P1476
CD84 is a survival receptor for CLL cells.
@en
P2093
D M Goldenberg
I Binsky-Ehrenreich
I Hazan-Halevy
P2860
P2888
P304
P356
10.1038/ONC.2013.31
P407
P577
2013-02-25T00:00:00Z